Important regulatory notice. GHK-Cu is not licensed by the MHRA for human or veterinary use in the United Kingdom. It is supplied to the laboratory market as a research-use-only reference compound. This page is a literature-context overview of how the published research has handled sex as a biological variable. It is not personal-use guidance and does not endorse any human or veterinary use of GHK-Cu by anyone of any sex.
Quick research summary. Most published GHK-Cu studies are in-vitro cell-culture experiments where the sex of the donor cell line is rarely the primary variable. Where animal-model and small human studies exist, they have been conducted in both sexes without any reported sex-specific safety signal in the cosmetic-formulation context. None of this constitutes a personal-use endorsement for anyone.
UK regulatory position
GHK-Cu is not a licensed medicine in the United Kingdom. The MHRA in April 2026 opened investigations into UK clinics making therapeutic claims about unregulated peptide products. Any ‘can people of sex X take this’ framing for an unlicensed substance is not appropriate for a UK retailer to answer in personal-use terms.
What the literature does and does not address
The historical GHK-Cu literature established the molecule as a naturally occurring component of human plasma in both sexes. Dermal-fibroblast studies are typically conducted on cell lines where sex of donor is documented but rarely is the primary experimental variable. The hair-follicle and wound-repair animal-model literature includes both sexes. Where published cosmetic studies have looked at topical GHK-Cu in human subjects, both men and women have participated. Sex-specific clinical pharmacokinetic data for any systemic administration of GHK-Cu in humans is not part of the public regulatory record.
Topical cosmetic context (separate regulatory space)
Topical GHK-Cu cosmetic products are sold to and marketed at both men and women in the cosmetic retail market. Usage of a regulated cosmetic product should follow the manufacturer’s product label.
Frequently Asked Questions
Does the published GHK-Cu research include men?
Yes. The molecule is naturally present in human plasma in both sexes, and small cosmetic-formulation studies have included both men and women.
Is there sex-specific safety data?
Sex-specific clinical pharmacokinetic data for systemic GHK-Cu in humans is not part of the public regulatory record because GHK-Cu is not a licensed medicine.
Should I take GHK-Cu?
Peptides Lab UK does not recommend any human use of GHK-Cu. We supply research-use-only laboratory reference compounds. Clinical questions should go to a registered prescriber.
Research use only. Products are not for human or veterinary use. This page is not medical or therapeutic advice.
